Neupogen Biosimilar Nivestym Matches Efficacy for Allogeneic HSCT Donor Mobilization

A single-center cohort analysis showed the biosimilar provided similar PBSC mobilization to originator filgrastim.

Related Keywords

Moazzam Shahzad ,Biosimilar Nivestym ,Researchgate Moazzam Shahzad ,University Of Kansas ,University Of Kansas Medical Center ,Moffit Cancer Center ,Kansas Medical Center ,Whsct ,Allogeneic ,Stem Cell ,Transplant ,Neupogen ,Nivestym ,Donor ,